Liquid Biopsy Analysis
Accelerating the future of liquid biopsies with digital PCR and next-generation sequencing
The term liquid biopsy in the context of oncology refers to the real-time monitoring of the dynamic alterations of a tumor through detection of cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or exosomes in blood or other fluid samples.
